李龙, 高光洁. κ-阿片受体激动剂U50488H通过调节巨噬细胞极化减轻体外循环致大鼠急性肺损伤的研究[J]. 实用临床医药杂志, 2024, 28(6): 46-50. DOI: 10.7619/jcmp.20233434
引用本文: 李龙, 高光洁. κ-阿片受体激动剂U50488H通过调节巨噬细胞极化减轻体外循环致大鼠急性肺损伤的研究[J]. 实用临床医药杂志, 2024, 28(6): 46-50. DOI: 10.7619/jcmp.20233434
LI Long, GAO Guangjie. κ-opioid receptor agonist U50488H alleviates acute lung injury induced by cardiopulmonary bypass rats by regulating macrophage polarization[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 46-50. DOI: 10.7619/jcmp.20233434
Citation: LI Long, GAO Guangjie. κ-opioid receptor agonist U50488H alleviates acute lung injury induced by cardiopulmonary bypass rats by regulating macrophage polarization[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 46-50. DOI: 10.7619/jcmp.20233434

κ-阿片受体激动剂U50488H通过调节巨噬细胞极化减轻体外循环致大鼠急性肺损伤的研究

κ-opioid receptor agonist U50488H alleviates acute lung injury induced by cardiopulmonary bypass rats by regulating macrophage polarization

  • 摘要:
    目的 探讨κ-阿片受体(KOR)激动剂U50488H是否通过调节巨噬细胞极化减轻体外循环(CPB)引发的大鼠急性肺损伤(ALI)。
    方法 将24只成年雄性清洁级SD大鼠(50~450 g)随机分为Sham组(假手术)、CPB组(CPB)和U50488H组(KOR激动剂+CPB), 每组8只。U50488H组于CPB前30 min静脉注射1.5 mg/kg U50488H。分别于CPB后0、1、2 h行动脉血气分析,计算肺泡-动脉氧分压差(A-aDO2)和呼吸指数(RI)。3组大鼠均在停CPB后2 h处死,取完整右肺下叶。采用重力法测定血管外肺水(EVLW), 采用苏木精-伊红(HE)染色观察肺组织形态学变化。采用酶联免疫吸附试验(ELISA)检测血浆酯多糖(LPS)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL- 6)和白细胞介素-4(IL-4)含量。采用免疫荧光法测定大鼠肺组织iNOS和CD206水平。
    结果 与Sham组比较, CPB组大鼠EVLW和TNF-a、血浆IL-6水平及肺组织iNOS表达增高,血浆IL-4水平和肺组织CD206表达降低,差异有统计学意义(P < 0.05)。CPB后0、1、2 h, CPB组的A-aDO2和RI、LPS高于Sham组, U50488H组的A-aDO2和RI、LPS低于CPB组,差异有统计学意义(P < 0.05)。CPB组大鼠出现严重肺损伤和肺泡内充血/出血,并伴有广泛的炎症细胞浸润, U50488H组肺损伤显著减轻。
    结论 KOR激动剂U50488H可促进CPB后大鼠肺巨噬细胞向M2表型极化,减轻炎症反应,增加抗炎因子释放,进而减少CPB后ALI的发生。

     

    Abstract:
    Objective To investigate whether κ-opioid receptor (KOR) agonist U50488H alleviates acute lung injury (ALI) induced by cardiopulmonary bypass (CPB) in rats by regulating macrophage polarization.
    Methods Twenty-four adult male clean grade SD rats (weight of 50 to 450 g) were randomly divided into Sham group (sham surgery), CPB group (CPB), and U50488H group (KOR agonist+CPB), with 8 rats in each group. The U50488H group was intravenously injected with 1.5 mg/kg of U50488H 30 minutes before CPB. Arterial blood gas analysis was performed at 0, 1 hour and 2 hours after CPB to calculate the alveolar-arterial oxygen gradient (A-aDO2) and respiratory index (RI). Rats of all three groups were euthanized 2 hours after CPB cessation, and the entire right lower lobe of the lung was excised. The extravascular lung water (EVLW) was measured using the gravimetric method, and lung tissue morphology changes were observed through hematoxylin-eosin (HE) staining. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of plasma lipopolysaccharide (LPS), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-4 (IL-4). Immunofluorescence was used to measure the levels of iNOS and CD206 in the lung tissue of rats.
    Results Compared to the Sham group, the CPB group of rats showed significant increases in extravascular lung water (EVLW) and levels of TNF-α, plasma IL-6 and lung tissue iNOS expression, as well as significant decreases in plasma IL-4 levels and lung tissue CD206 expression (P < 0.05). At 0, 1 hour and 2 hours after CPB, A-aDO2, RI and LPS in the CPB group weresignificantly higher than those in the Sham group, and A-aDO2, RI and LPS in the U50488H group were significantly lower than those in the CPB group (P < 0.05). The rats in the CPB group showed severe lung injury with alveolar congestion/bleeding and extensive infiltration of inflammatory cells, while lung injury was significantly reduced in the U50488H group.
    Conclusion The KOR agonist U50488H can promote M2 polarization of lung macrophages in rats after CPB, reduce inflammatory response, increase anti-inflammatory factor release, and thereby reducing the occurrence of ALI after CPB.

     

/

返回文章
返回